Black Diamond Therapeutics, Inc. Common Stock (BDTX)

Typically moves ±5.44% on earnings
EARNINGS ANALYTICS
event_note Approx. Next Earnings: ~2026-11-06 APPROXIMATE
search

Since Aug 12, 2021, Black Diamond Therapeutics, Inc. Common Stock (BDTX) has reported earnings 21 times. On average the shares move ±5.44% post-earnings, with a positive reaction 52.4% of the time. Its largest post-earnings gain was +10.29% (May 12, 2025) and its largest decline was -22.64% (Dec 03, 2025). The next earnings report is predicted for 2026-11-06 (approximate).

Earnings reactions

How BDTX moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

21

Avg Abs. Movement

±5.44%

Positive %

52.4%

Negative %

47.6%

Historical Earnings Statistics

Date Timing Earnings move SEC Filing
Aug 05, 2026 ☽ POST +7.87% open_in_new
May 07, 2026 ☀ PRE -3.36% open_in_new
Mar 16, 2026 ☽ POST +1.37% open_in_new
Dec 03, 2025 ☀ PRE -22.64% open_in_new
event

Earnings Count

21

Total earnings in dataset

trending_up

Avg Abs. Movement

±5.44%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 20 →
20
Funds holding
$13300083
Total value held
Buying
15 added · 4 reduced
Blackrock, Inc.
$7246613 +253.90%
State Street Corp
$971274 +145.89%
Bank Of America Corp /De/
$765004 +262.28%
Northern Trust Corp
$675979 -21.37%

Frequently asked about BDTX earnings

When does Black Diamond Therapeutics, Inc. Common Stock report earnings next? expand_more

Black Diamond Therapeutics, Inc. Common Stock (BDTX)'s next earnings date is approximate for 2026-11-06. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does BDTX stock move after earnings? expand_more

Over 21 reports, BDTX has moved an average of ±5.44% the session after earnings, closing higher 52.4% of the time.

What was BDTX's biggest post-earnings move? expand_more

BDTX's largest post-earnings gain on record was +10.29% on May 12, 2025, and its largest decline was -22.64% on Dec 03, 2025.

Where can I find Black Diamond Therapeutics, Inc. Common Stock's SEC filings? expand_more

All of Black Diamond Therapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.